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Edited by Maurice MontalAbstract Voltage-gated potassium (Kv) channel subtypes local-
ize to the plasma membrane of a number of cell types, and the
sarcolemma in myocytes. Because many signaling molecules con-
centrate in subdomains of the plasma membrane, the localization
of Kv channels to these sites may have important implications for
channel function and regulation. In this study, the association of
the voltage-gated potassium channel Kv1.5 with a speciﬁc sub-
type of lipid rafts, caveolae, in rat and canine cardiac myocytes
has been investigated. Interactions between caveolin-3 and b-dys-
troglycan or eNOS, as well as between Kv1.5 and a-actinin were
readily detected in co-immunoprecipitation experiments, whereas
no association between Kv1.5 and caveolin-3 was evident. Wide-
ﬁeld microscopy and deconvolution techniques revealed that the
percent co-localization of Kv1.5 with caveolin-3 was extremely
low in atrial myocytes from rat and canine hearts (8 ± 1% and
12.2 ± 2%, respectively), and limited in ventricular myocytes
(11 ± 4% and 20 ± 3% in rat and canine, respectively). Immuno-
electron microscopic imaging of rat atrial and ventricular tissues
showed that Kv1.5 and caveolin-3 labeling generally did not over-
lap. In HEK293 cells stably expressing the channel, Kv1.5 did
not target to the low buoyant density raft fraction along with ﬂo-
tillin but instead fractionated along with the non-raft associated
transferrin receptor. Taken together, these results suggest that
Kv1.5 is not present in caveolae of rat and canine heart.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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myocytes1. Introduction
Studies in cultured mouse ltk-cells [1,2], tsA201 cells, mouse
brain [3], pancreatic b-cells [4] and Jurkat T-lymphocytes [5]
have found several subtypes of voltage-gated potassium (Kv)
channels to be sorted to specialized domains in the plasma
membrane called lipid rafts. Because lipid rafts are thought
to concentrate signaling molecules for more eﬃcient transduc-
tion, this targeting may provide a mechanism for diﬀerential
regulation of targeted channels. A lipid raft subgroup of par-
ticular interest in myocytes is caveolae, which are ﬂask-like
invaginations of the surface membrane containing the mus-
cle-speciﬁc caveolin-3.*Corresponding author.
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lin-3, and a third type of caveolin, caveolin-2, although studies
of the subtypes have indicated that caveolin-2 requires co-
expression of caveolin-1 or -3 in order to express in the plasma
membrane [6]. Mice lacking caveolin-3 show a defective T-tu-
bule system and changes in the dystrophin–glycoprotein com-
plex distribution associated with the loss of caveolae in skeletal
muscle [7] and a progressive hypertrophic cardiomyopathy [8].
Overexpression of caveolin-3 leads to severe cardiac tissue
damage and ﬁbrosis and a prolonged QRS duration in trans-
genic mice [9]. Several proteins are associated with these do-
mains including c-Src, G-protein a-subunits [10], H-Ras [11]
and eNOS [12] as well as various receptors [13,14] including
the b2-adrenergic receptor [15]. Caveolae have been implicated
in the regulation of targeted signal cascades (reviewed in
[16,17]), in clathrin-independent endocytosis (reviewed in
[18]), calcium signaling (reviewed in [19]), and in cholesterol
traﬃcking (reviewed in [17]). Caveolins may also stabilize the
caveolar invagination and slow the dynamin-dependent inter-
nalization process [18].
Here, we have studied the molecular correlate of IKUR, Kv1.5
[20,21], a channel that is highly expressed in human atrial myo-
cytes [20]. IKUR is an important contributor to the repolariza-
tion phase of the atrial action potential, but appears to have
little electrophysiological role in the ventricle. Therefore,
Kv1.5 has generated signiﬁcant interest as an atrial-speciﬁc tar-
get for the treatment of atrial ﬁbrillation [22,23]. It would be of
great interest to know whether Kv1.5 localizes to lipid rafts in
normal adult mammalian cardiac myocytes where the proteins
are expressed at physiological levels, and more speciﬁcally
whether it localizes in caveolae in association with caveolin-3.
Signiﬁcantly, many of the same signaling molecules known
to localize in caveolae aﬀect Kv1.5. Kv1.5 can be modulated
by protein kinases such as Src [24] and PKA [25] and IKUR
is inﬂuenced by b2-adrenergic stimulation [26]. Localization
to caveolae appears to be a dynamic process with several
receptors, such as the b2-adrenergic receptor [27] and the mus-
carinic acetylcholine receptor [28] entering caveolae upon ago-
nist stimulation; receptors such as the adenosine A1 receptor
[13] translocate out of caveolae upon activation. It is conceiv-
able that regulation of Kv1.5 could similarly involve regulated
localization of the channel or localization of molecules that
regulate the channel. Intriguingly, Kv1.5 may be inactivated
by phosphorylation [24], and Src kinase, which has been
shown to regulate Kv1.5 activity, appears to translocate out
of caveolae upon activation [29].
In the study reported here, we have used biochemical meth-
ods, wide-ﬁeld microscopy combined with deconvolutionblished by Elsevier B.V. All rights reserved.
6040 J. Eldstrom et al. / FEBS Letters 580 (2006) 6039–6046techniques and immunoelectron microscopy to investigate the
spatial localization of Kv1.5 and caveolins in rat and canine
cardiac myocytes. We show that, from myocyte lysates,
Kv1.5 does not coimmunoprecipitate with the major caveolar
coat protein, caveolin-3, nor does the channel co-localize
appreciably with this marker for caveolae. Also, unlike
caveolin, which sediments in lipid raft fractions, Kv1.5 sedi-
ments into non-lipid raft fractions from cardiac and cultured
HEK293 cell membranes.2. Materials and methods
2.1. Preparation of canine heart lysates
Canine atrial and ventricular tissue was obtained from heartworm-
negative mongrel dogs (20–30 kg) as previously described [23]. Dogs
were anesthetized with intravenous pentobarbital sodium (30 mg/kg)
and fentanyl citrate (15 lg/kg) and placed on positive-pressure ventila-
tion. A catheter was inserted into the right femoral artery, and the dogs
were exsanguinated. A left lateral thoracotomy was performed through
the ﬁfth intercostal space, and the heart was arrested. All surgical pro-
cedures and experimental protocols were approved by the Cleveland
Clinic Foundation Institutional Animal Care and Use Committee
(Cleveland, OH).
For rat samples, adult male Wistar rats weighing between 250 and
300 g were killed with an overdose of sodium pentobarbital (65 mg/
kg body weight) and 2 U of heparin sodium USP. These procedures
were approved by the UBC Committee on Animal Care (Vancouver,
BC). The freshly excised ventricular or atrial tissue was added to ice
cold non-denaturing lysis buﬀer and homogenized as described in
[23] and lysates were processed as described previously [30]. Following
transfer to PVDF membranes the samples were probed with either
rabbit anti-Kv1.5 (1:10000; developed in our laboratory [23], mouse
anti-caveolin-3, rabbit anti-caveolin-1, mouse anti-b-dystroglycan
(1:10000; BD Bioscience), mouse anti-caveolin-2 (1:5000; BD Biosci-
ence), rabbit anti-eNOS (1:5000; Chemicon Int.), or mouse anti-actinin
(1:10000, Sigma). HRP conjugated goat anti-rabbit IgG or sheep
anti-mouse (1:10000; Jackson Laboratories) were used as secondary
antibodies for detection using a chemiluminescent reagent (Western
Lightning, Perkin–Elmer).
2.2. Myocyte preparation
Atrial myocytes were dissociated from canine atrial specimens using
a chunk dissociation technique [23], and rat myocytes using methods
described by Scriven et al. [31] except that when the hearts began to
soften, atria were removed separately, and triturated in physiological
saline. Canine ventricular myocytes were isolated using the segmental
coronary artery perfusion technique [32].
2.3. Immunolabeling and wide-ﬁeld microscopy
Myocytes, stored in PBS-azide solution after ﬁxation [23], were pla-
ted onto poly-L-lysine coated coverslips. For rat myocytes, after block-
ing, the rabbit polyclonal Kv1.5 primary antibody, diluted in antibody
buﬀer (150 mM NaCl, 15 mM Na3 Citrate, 3 mM NaN2 with 1% BSA,
2% (v/v) goat serum and 0.05% (v/v) Triton X), was incubated with the
cells ﬁrst, followed by secondary antibody conjugated with ﬂuorescein
isothiocyanate (FITC); then the mouse anti-caveolin-3 monoclonal
antibody, followed by a Texas Red secondary antibody. All primary
antibodies were incubated overnight; the secondary antibodies were
incubated for 1.5 h. Immunolabeling of canine samples was as previ-
ously reported [23].
Images were acquired using a Nikon Diaphot 200 inverted micro-
scope. 2D images (magniﬁcation, ·600) acquired from a thermoelectri-
cally-cooled CCD camera through the whole cell at 0.25 lm
intervals were stacked into 3D images after subtraction of dark current
and background, and deconvolved using an empirically determined
point-spread-function [31]. Dual ﬂuorescence beads were added to
mounting media and used to guide the overlapping of two images ac-
quired at diﬀerent emission wavelengths. The threshold intensity was
applied to remove the noise on images before analyzing the data. Data
were presented as means ± S.E.M. N refers to the number of cells col-
lected from 3 to 4 animals.2.4. Preparation of Tokuyasu sections and immunolabeling
After overdose with Pentobarbitol, rats were perfused via the right
ventricle with 10 ml of cold PBS using a peristaltic pump before a
10 min perfusion with 4% paraformaldehyde in 0.1 M phosphate buﬀer
(PB). After removal of the heart, the tissue was cut into smaller sec-
tions under ﬁxative. After a 50 mM buﬀered glycine aldehyde block,
the small tissue pieces were inﬁltrated (37 C with constant rotation)
with increasing concentrations of buﬀered gelatin up to 12% gelatin.
The gelatin was allowed to harden at 4 C and the tissue pieces were
cut out and placed into 2.3 M sucrose in 0.1 M PB and allowed to ro-
tate overnight at 4 C. Cryoprotected tissue was mounted onto cryo-
pins and frozen in liquid nitrogen. Thin sections were cut using a Leica
Ultracut T (Leica Microsystems, Canada) and a 35 cryo-diamond
knife (Diatome). Ribbons were picked up in a drop of 1% methyl cel-
lulose and 1.15 M sucrose, allowed to thaw on copper grids and imme-
diately placed section side down onto a plate of hardened 2% buﬀered
gelatin for short-term storage.
For immunolabeling of Tokuyasu sections (adapted from [33]), grids
were ﬂoated on drops of: (a) 0.1 M PB (20 min); (b) 1% glycine (5 min);
(c) PB (3 · 3 min); (d) PBS/3% BSA (10 min); (e) mouse anti-caveolin-3
and rabbit anti-Kv1.5 antibody diluted 1/10 and 1/120 in PBS/3% BSA
(30 min); (f) PB (5 · 3 min); (g) PBS/3% BSA (5 min); (h) anti-mouse
IgG-10 nm gold (Sigma) and anti-rabbit IgG-5 nm gold (20 min; Ted
Pella Inc.); (i) PB (5 · 3 min); (j) dH2O (10 · 3 min); (k) 2:8 ratio of
2% uranyl acetate (UA) to 4% methyl cellulose (MC) on ice (5 min),
excess UA/MC was wicked away and samples air dried. Images were
acquired using a Hitachi H7600 Transmission Electron Microscope.
2.5. Sucrose gradient raft fractionation
HEK293 cells, stably expressing Kv1.5, from ﬁve 95% conﬂuent
T75 Culture Flasks were suspended in 5 ml of ice-cold homogenization
buﬀer (150 mM NaCl, 20 mM Na2PO4, 2 mM NaH2PO4, 20% (w/v)
glycerol) and homogenized in a Dounce Homogenizer on ice. The
homogenate was then sonicated (Vibra-Cell Ultrasonic Processor,
Sonics and Materials Inc.) 3–30 s pulses with 1 min cooling periods
between. The homogenate was then centrifuged at 10000 rpm for
11 min at 4 C (SW55 Rotor) to pre-clear the sample of nuclei and deb-
ris. The supernatant was then centrifuged at 55000 rpm for 33 min at
4 C to isolate the membrane fraction. The supernatant from this spin
was saved as the cytosolic fraction. The membrane pellet was resus-
pended and incubated 15 min in ice-cold solubilization buﬀer
(25 mM Mes pH 6.5, 150 mM NaCl, 1% Triton X-100 plus protease
inhibitors). Solubilized membrane (2.0 ml) was transferred to a 12 ml
ultracentrifuge tube and 2.0 ml of ice-cold 80% sucrose in Mes-Buf-
fered Saline (MBS; 25 mM Mes pH 6.5, 150 mM NaCl) was added
and mixed thoroughly. Four millilitres of 30% sucrose in MBS was lay-
ered gently on top of the ﬁrst layer and then 4 ml of 5% sucrose in
MBS above the 30%. The samples were then spun at 35000 rpm for
12.5 h at 4 C in a SW41 Ti Rotor. Twelve 1-ml fractions were col-
lected from the top of the gradient and the pellet was washed exten-
sively with PBS before being solubilized in MBS with 2% SDS. The
re-suspended pellet was centrifuged at 21000 · g and the supernatant
run with the rest of the gradient fractions on a 10% SDS–PAGE gel
as the fractionation pellet (FP). The fractions were probed with mouse
anti-human transferrin receptor (Zymed Laboratories), mouse anti-
ﬂotillin-1 (BD Transduction) and rabbit anti-Kv1.5 antibodies.3. Results
3.1. Kv1.5 and caveolin-3 are present in rat and canine cardiac
tissue
We have used several approaches to investigate the interac-
tion of Kv1.5 and caveolins in cardiac myocytes. Since caveo-
lin-3 is found predominantly in muscle tissue [34], we initially
employed Western blotting to assay for Kv1.5, caveolin-2,
and caveolin-3 in samples prepared from rat and canine atrium
and ventricle (Fig. 1). The rat atrium and ventricular samples
are shown to the left of the canine samples and Kv1.5 is appar-
ent as a faint band of approximately 83 kDa in all lanes. In con-
trast, caveolin-3 in the middle panels was highly expressed in all
samples. Caveolin-2 (Fig. 1, bottom) could be detected only in
Fig. 1. Kv1.5 and caveolin-3 are expressed in rat and canine atrial and
ventricular tissues. Homogenates were prepared from atrial or
ventricular tissue and immunoblotted with anti-Kv1.5 (upper panels),
anti-caveolin-3 (middle panels), or anti-caveolin-2 (lower panel) as
indicated to the left of the blots (see Section 2) (RA – rat atrial lysate;
RV – rat ventricular lysate; CA – canine atrial lysate; CV – canine
ventricular lysate; LM – mouse ltk-cells).
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the caveolin-2 antibody could detect protein in other cell systems,
we probed extracts frommouse ltk-cells (LM lane in Fig. 1, bot-
tom panel), as ﬁbroblasts are known to express caveolin-2 [34].
3.2. Kv1.5 and caveolin-3 do not co-immunoprecipitate
Having established the presence of Kv1.5 and caveolins in
the tissue lysates, co-immunoprecipitations were carried out
to determine whether Kv1.5 physically interacts with caveo-
lin-3 in these tissues (Fig. 2). Results from rat and canine
atrium and ventricle are presented in the same manner as inFig. 2. Kv1.5 and caveolin-3 fail to co-immunoprecipitate from rat and canin
caveolin-3 immunoprecipitations from rat (left side of ﬁgure) and canine (righ
above each lane and the antibodies used to probe the blots are indicated to the
but not co-immunoprecipitation with caveolin-3, while the lower panels show
Kv1.5. (B) Western blots showing positive controls of known co-immunopr
panels), eNOS with caveolin-3 (left lower panel), and b-dystroglycan with caFig. 1, with the rat samples shown to the left (Fig. 2). As
shown in Fig. 2A (upper panels), antibody to Kv1.5 eﬃciently
immunoprecipitated Kv1.5 from both rat and canine atrial and
ventricular tissue. However, antibody to caveolin-3 failed to
co-immunoprecipitate Kv1.5, as did control reactions lacking
a precipitating antibody (-Ab lanes). A similar result was
obtained with the reverse experiment (Fig. 2A, lower panels);
antibody to caveolin-3 clearly immunoprecipitated caveolin
as shown in lanes 4 and 6 (left panels) and lanes 3 and 6 (right
panels), but failed to bring down with them detectable levels of
Kv1.5 in the rat or canine samples, as indicated by the lack
appropriate bands in the lanes probed with the anti-Kv1.5.
To ensure that our protocol was eﬀective for co-immuno-
precipitation of proteins known to interact with Kv1.5 and
caveolin-3 [12,35,36], we carried out a number of control
experiments. In the ﬁrst set of controls (Fig. 2B), immunopre-
cipitates of Kv1.5 were probed with an antibody to sarcomeric
a-actinin and, as expected, a band corresponding to actinin
was found in each of the rat and canine cardiac samples
(Fig. 2B, upper panels). Similarly, antibody to caveolin-3
co-immunoprecipitated eNOS in the rat ventricle (left lower
panel) and co-immunoprecipitated b-dystroglycan from canine
atrial lysates (right lower panel). None of these proteins were
detected in the antibody-free controls (Fig. 2).
3.3. Kv1.5 and caveolin-3 show minimal co-localization in
deconvolved ﬂuorescent images
Having demonstrated that Kv1.5 and caveolin-3 do not co-
immunoprecipitate from cardiac myocytes, we investigated
whether the channel is present in the caveolar domain, as the
channel could localize to caveolae without directly interacting
with caveolins. To test this possibility, we examined the distri-
bution of caveolin-3 and Kv1.5 in myocytes using wide-ﬁeld
microscopy and deconvolution techniques. Fig. 3 shows repre-
sentative examples of computer-deconvolved images of Kv1.5
and caveolin-3 immunolabeled rat (Fig. 3A) and caninee atrial and ventricular homogenates. (A) Western blots of Kv1.5 and
t side of ﬁgure) cardiac tissue. The precipitating antibodies are indicated
left of the blots. The upper panels show immunoprecipitation of Kv1.5
immunoprecipitation of caveolin-3 but not co-immunoprecipitation of
ecipitating proteins in heart. These include actinin with Kv1.5 (upper
veolin-3 (right lower panel). Other labels are as for Fig. 1.
Fig. 3. Lack of co-localization of Kv1.5 and caveolin-3 in wide-ﬁeld images of rat and canine cardiac myocytes. Rat (A) and canine (B) atrial (above)
and ventricular (below) myocytes labeled with antibodies speciﬁc for Kv1.5 (green) and caveolin-3 (red), colocalized voxels are white. All of the
images are 3D reconstructions, showing both X–Y and X–Z views of individual myocytes. (A) XY views are 6 lm thick, and their corresponding XZ
views are 1 lm thick. Scale bar is 5 lm. The ﬁrst X–Z view of the rat ventricular myocyte is at the level of the intercalated disc and highlights
the intricate topology of this region as well as the higher levels of Kv1.5 staining. (B) XY view of the atrial myocyte is 7 lm thick, and the XY view of
the ventricular myocyte is 3 lm thick. Their corresponding XZ views are 1 lm thick. Scale bar is 5 lm. The double-headed arrow points to the
intercalated disc, the single arrow points to the Z-line.
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(red) and Kv1.5 with Alexa488 (green). In these 3D reconstruc-
tions, the resolution is calculated to be 122 nm in the X–Y-
plane and 250 nm in the Z-plane (voxel size). In the rat atrial
(top) and ventricular samples (bottom) it can be seen that cave-
olin-3 is highly expressed across the surface of the myocytes, as
clearly conﬁrmed in the cross-sectional images. In contrast,
Kv1.5 expression is much lower, except at the intercalated disc,
where Kv1.5 staining is very intense. In the ventricle, excluding
the intercalated disc, Kv1.5 staining is most intense at the Z-
line, adjacent to but distinct from the striated pattern of cave-
olin-3 staining; colocalization analysis revealed that 11 ± 4% of
the voxels positive for Kv1.5 were also positive for caveolin-3
(n = 4) in these cells. In rat atrial myocytes (Fig. 3A), Kv1.5
weakly labeled the surface membrane and the interior of the
cell, and only 8 ± 1% of voxels that showed Kv1.5 also showed
caveolin-3 (n = 5). The ﬁndings in canine myocytes were simi-
lar. Caveolin-3 immunolabeling was also marked at the cell
surface in atrial cells (Fig. 3B, upper panel), and at the surface
and along Z-lines in canine ventricular myocytes (lower panel).
Kv1.5 was also well expressed in both canine atrial and ven-
tricular myocytes with strong surface and Z-line expression
in both types of cell. Despite the widespread distribution of
both proteins, colocalization in the atrial myocytes was poor
at 12 ± 2%. Apparent colocalization was greater in the ventri-
cle at 20 ± 3% (P < 0.02). Values are means ± S.E.M., with an
n of 5 for each cell type.
3.4. Immuno-EM conﬁrms that Kv1.5 and caveolin-3 are
diﬀerentially distributed in cardiac tissue
To examine the distribution of Kv1.5 and caveolin-3 in car-
diac tissue at a higher resolution than the 122 nm · 122 nm(X and Y) by 250 nm (Z) possible using the deconvolution
technique, we immunogold labeled 70 nm thick Tokuyasu
sections (see Section 2) of rat atrial and ventricular tissue
and examined them by electron microscopy (Fig. 4). In these
samples, caveolin-3 was immediately detectable as 10 nm gold
particles distributed both at the cell surface and immediately
below in ﬂask-like structures (Fig. 4A). In contrast, Kv1.5
was labeled with 5 nm gold particles and more rarely seen
(identiﬁed by arrows in panels A–C). Despite the low density
of Kv1.5 staining in both atrial (Fig. 4A, B) and ventricular
samples (Fig. 4C), Kv1.5 was well separated from caveolin-3
labeling. In none of the EM sections illustrated was coinci-
dent labeling of the two proteins found. Overall, even
Kv1.5 and caveolin near-juxtaposition was extremely rare; 5
and 10 nm gold particles were found within 10 nm of each
other in less than 1% of the sections examined. However, it
is important to note that Kv1.5 and caveolin, while labeling
distinct domains, could be found within 100 nm (i.e., within
the voxel size for wide-ﬁeld microscopy) in about 20%
of TEM images positive for both proteins (as seen in
Fig. 4A, B).
The TEM image of an atrial section (Fig. 4A) illustrates a
segment of surface membrane showing at least one clear cave-
olus, a segment of a Z-line, surface and internal Kv1.5 staining
possibly corresponding to SR localization or as vesicular
cargo. Fig. 4B shows a lateral membrane region rich in caveo-
lae with two 5 nm gold particles indicated by the arrow in the
enlargement of the boxed region. The ventricular image
(Fig. 4C) illustrates an intercalated disc region. The pre-
dominant labeling of Kv1.5 found along the Z-lines and at
the intercalated discs conﬁrms the observations made using
ﬂuorescence microscopy (Fig. 3).
Fig. 5. Kv1.5 does not localize to the lipid raft fraction in HEK293
cells or rat ventricular tissue. (A) HEK293 cells stably expressing
Kv1.5 and (B) Rat ventricular tissue were mechanically disrupted and
the membrane fractions were separated by discontinuous sucrose
gradient after solubilization in 1% Triton X-100 at 4 C. Twelve
fractions were collected starting from the top of the gradient and
analyzed by Western blot. Flotillin-1 was used to delineate the raft
fraction and the transferrin receptor the non-raft fractions. C is the
supernatant from a 128000 · g spin that pelleted the membranes and
represents the cytosolic fraction. P is the soluble protein extracted from
the sucrose gradient pellet with 2% SDS.
Fig. 4. Kv1.5 and caveolin-3 do not co-localize in immuno-EM images
of rat cardiac myocytes. Images are of rat atrial (A and B) and
ventricular (C) tissue. Cryosections (70 nm) were immunogold labeled
for Kv1.5 (5 nm gold; indicated by black arrows) and caveolin-3
(10 nm gold). Boxed region in (B) is shown at higher magniﬁcation in
the inset. Image in (C) shows a region through the intercalated disc.
Other than in the inset, scale bars represent 100 nm (In (A): PM,
plasma membrane; Z, Z-line; C, caveolus).
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gradient fractionations
Caveolae exist as a subtype of lipid rafts; caveolin-1, for
example, sediments in the lipid raft fraction in sucrose gradi-
ents [37]. In order to examine whether the channel could be
biochemically localized to rafts, be they caveolar or not,
membrane fractions from both HEK293 cells stably express-
ing Kv1.5 and from rat ventricular tissue were solubilized in
1% Triton X-100 at 4 C and then fractionated in a sucrose
step gradient. Twelve 1-ml fractions were removed from the
top of the gradient and samples from each fraction were
run on a denaturing gel. The light buoyant density fraction
(Fraction 5) was identiﬁed using the raft marker ﬂotillin
(Fig. 5A lower panel) as our HEK293 cells express very little
caveolin-1 (not shown). The transferrin receptor was used as
a marker for non-raft associated fractions (Fig. 5A and B
upper panels), and was found in fractions 9–12 as well as
in the pellet from the fractionation (FP). Kv1.5 co-sedi-
mented with the transferrin receptor in fractions 9–12, and
was absent from fraction 5 in both the cultured cells
(Fig. 5A, middle panel) and the cardiac tissue sample
(Fig. 5B, lower panel). Immunoprecipitation reactions to
concentrate channel protein conﬁrmed that Kv1.5 is abun-
dant in fraction ten but absent from the ﬂotillin positive frac-
tion ﬁve (data not shown).4. Discussion
In this study we have studied the localization of Kv1.5 by
examining the direct physical interaction of the channel with
the major caveolar coat protein, caveolin-3 using biochemical
techniques, and the spatial distribution of the channel using
wide ﬁeld deconvolved and EM images of labeled myocytes.
These experiments are the ﬁrst to directly address the colocal-
ization of Kv1.5 and caveolins in native cardiac tissues. In
addition, we have examined the relationship of the channel
and lipid rafts, membrane fractions characterized by a light-
buoyant density and insensitivity to extraction by Triton
X-100 at 4 C. In isolated myocytes and cardiac tissue, the pro-
teins did not co-immunoprecipitate (Fig. 2A) nor did Kv1.5
and caveolin-3 appreciably colocalize (Figs. 3 and 4), although
interactions with other proteins known to associate with Kv1.5
or caveolin were detected (Fig. 2B). These observations were
supported by fractionation results in which Kv1.5 was detected
only in non-raft fractions in both HEK293 cells and in cardiac
tissue (Fig. 5).
The relationship between Kv1.5 and caveolin has been con-
troversial. Using co-immunoprecipitation experiments, Mar-
tens et al. [2] found no direct interaction between Kv1.5 and
caveolin in cultured cells. However, using doubly transfected
COS-7 cells overexpressing the two proteins, Folco et al., re-
ported signiﬁcant interaction between Kv1.5 and caveolin-3
[38]. And, using a similar over-expression system, Martens
et al. [1] found that immature Kv1.5 copuriﬁes with immuno-
isolated caveolae. Here, we have examined the phenomenon in
native tissue in which the proteins are endogenously expressed,
rather than in transfected heterologous cell lines with the
attendant issues surrounding overexpression of non-native
proteins. Thus, it would appear that Kv1.5 and caveolin-3 sort
independently in cardiac tissue from the rat and dog. Whether
the channel can interact with caveolins in other species or
tissues remains an open question.
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action of Kv1.5 with caveolin-2. However, while we were able
to detect caveolin-2 in rat atrial and ventricular lysates (Fig. 1,
bottom panel), we found no caveolin-2 in isolated rat cardiac
myocytes despite repeated immunolabeling attempts under
varied conditions (data not shown). Woodman et al. [8] simi-
larly failed to ﬁnd caveolin-2 in myocytes and reported that
caveolin-2 expression is limited to the endothelium and endo-
cardium. Our ﬁndings are consistent with their data; in similar
experiments using canine tissue we were unable to detect cave-
olin-2 at all (Fig. 1). Perhaps caveolin-2 was absent in the tis-
sue we employed or perhaps our result was due to the inability
of the monoclonal antibody to recognize the canine protein,
which is more diverged from human caveolin-2 than is the rat.
In their report of an association between Kv1.5 and immu-
no-isolated caveolae, Martens et al. [2] described an association
of immature core glycosylated Kv1.5 with immuno-isolated
caveolae in their mouse ltk-cells, but found that post-transla-
tionally modiﬁed Kv1.5 was absent from these caveolae. In
our experience, cardiac myocytes lack signiﬁcant amounts of
the immature protein, as indicated by a single band migrating
at approximately 83 kDa in cardiac lysate Western blots. This
is apparent comparing the single Kv1.5 band in Fig. 1 to the
doublet of mature and immature forms of the channel seen
in HEK cells (Fig. 5 and [39]), suggesting that in native cells
the channel is more eﬃciently processed. This lack of signiﬁ-
cant pools of immature channels may explain our ﬁndings that
Kv1.5 and caveolin-3 did not co-immunoprecipitate or colocal-
ize in cardiac myocytes (Figs. 2–4). It is possible that in heter-
ologous over-expression systems some immature protein
reaches the cell surface and associates with caveolae or, con-
ceivably even, overexpression of the channel leads to an intra-
cellular interaction with vesicles harboring caveolin. In mature
cardiac myocytes, on the other hand, our data would indicate
that neither process occurs to any signiﬁcant extent.
The distribution of Kv1.5 in the myocytes is of interest, irre-
spective of its relationship to caveolin. In previous work with
canine myocytes, we found that the results of Kv1.5 localiza-
tion studies are very much dependent upon the anti-Kv1.5
antibody used [23]. The antibody employed here was devel-
oped by us, is highly speciﬁc to Kv1.5 [23] and has been used
by others [40]. This antibody has enabled us to compare the
distribution of Kv1.5 in rat and canine myocytes to that ob-
served by others in rat [41], mouse [42] and human [43]. The
observation most consistent across studies is that Kv1.5 stain-
ing is low on lateral membranes and Z-lines and enriched at
the intercalated disc. This is true in rat, canine and human,
while in mouse the labeling appears to be more generally at
the cell surface and at Z-lines, at least in ventricular cells [42].
While expression at the cell surface is consistent with Kv1.5
function, it is not obvious why Kv1.5 should localize so
strongly to the intercalated disk. It is diﬃcult to envision a
functional role for an ion channel in that structure. Interest-
ingly, other channels have also been found to be largely local-
ized to the intercalated disc, including Kv4.2 [41] and Nav1.5
[44,45]. A sodium–hydrogen exchanger has also been localized
to this domain [46]. The Nav1.5 sodium channel resident at the
intercalated disk has been suggested even to play a role in ini-
tiation and conduction of the action potential [44,45]. Thus, it
is possible that ion channels are somehow functional in the
intercalated disk. Alternatively, the intercalated disk may
merely serve as a storage site for excess channels or, perhaps,these proteins play a structural role at this site. The ﬁnding
of Kv1.5 staining at the Z-lines might also reﬂect internal
stores of the channel or, perhaps, localization of the channel
to T-tubules or T-tubule-like structures.
Unlike Kv1.5, caveolin largely localizes to the cell membrane
in ﬂuorescent imaging experiments. Very little Kv1.5 channel
staining overlaps with the abundantly expressed caveolin-3
protein (Fig. 3A, B). Given the relatively low resolution of
the ﬂorescence imaging system (calculated to be 122 nm in
the X–Y-plane and 250 nm in the Z-plane), the 8–20% appar-
ent colocalization seen under the light microscope at this voxel
size is not strong evidence that the two proteins are associated,
since results with electron microscopy showed a similar 20% of
immunogold-labeled Kv1.5 and caveolin molecules lie within
such voxel spaces yet are clearly separated (Fig. 4). These re-
sults highlight the complementary value of these two imaging
techniques. While the TEM experiments greatly improved
the resolution and enabled us to look more carefully at the
channel distribution in relation to caveolin-3 and several
ultra-structural elements, the ﬂuorescent images gave a more
general sense of staining that is impossible to appreciate when
tightly focused on speciﬁc regions of the cell.
The TEM images showed sparse Kv1.5 staining and this is
expected given the calculated channel density in rat atrium.
Assuming a speciﬁc capacitance of 0.01 pF/lm2 (average atrial
myocyte capacitance of 40.7 pF and therefore a cell surface
area of about 4070 lm2), a maximal slope conductance of
103 pS/pF [47], a maximal open probability of 0.80, and a sin-
gle channel conductance of 13 pS for Kv1.5, then we would ex-
pect to see 1 channel per 10 lm2. If we decrease the open
probability to 0.5 then we would expect a channel in every
6.3 lm2. These calculations would indicate that in each 6–
10 lm length of surface membrane examined in the 70 nm
thick EM sections, we would expect to see less than one chan-
nel. Depending on how much of the channel partitioned into
each given section there is the possibility to label each subunit
in the channel, which would result in up to four labels per
channel, depending on the degree of steric hindrance. If the
average thickness of a myocyte were 12 lm then we would ex-
pect that each myocyte would produce 170 sections. From
these numbers it would seem that the occurrence of functional
channels in the lateral membranes is quite low especially given
the apparent concentration at the intercalated disc region
shown in the ﬂuorescent images (Fig. 3). Therefore, it was en-
tirely expected in the TEM images of immunolabeled myocytes
that channel abundance was quite low. We have no way of cal-
culating how many non-functional channels there may be,
both at the surface and those in intracellular compartments,
such as in early endosomes, which would be detected in the
immunolabeling experiments but would not contribute to cur-
rent density.
Given that we could ﬁnd little evidence of Kv1.5 localization
to caveolae, it was important to establish whether the channel
partitioned into non-caveolar lipid rafts in our heterologous
expression system (HEK293 cells) or in cardiac tissue. No
Kv1.5 immunoreactivity was observed in the raft fraction from
HEK293 cells or the rat ventricular sample; the majority of the
channel protein clearly fractionated with the non-raft marker,
the transferrin receptor (Fig. 5). Similarly, as stated earlier,
Martens, et al failed to ﬁnd mature, glycosylated Kv1.5 in
the raft fraction of heterologous cells [2]. In addition, in fur-
ther electrophysiological experiments, treatment of canine at-
J. Eldstrom et al. / FEBS Letters 580 (2006) 6039–6046 6045rial myocytes with methyl-b-cyclodextrin, a drug that disrupts
lipid rafts by depleting the cell membrane of cholesterol, re-
sulted in a decrease in the instantaneous current (ITO; under-
lain by Kv4.2) but had no obvious eﬀects on the sustained
current which is largely underlain by Kv1.5 [23] (data not
shown).
Also inconsistent with an association of Kv1.5 with caveo-
lae, we have shown that pretreatment of HEK293 cells with
the actin-depolymerizing agent, cytochalasin D leads to a large
increase in Kv1.5 surface expression [35]. It is known that sur-
face caveolin-1 levels are decreased by disruption of the actin
cytoskeleton in CHO cells, which, like HEK cells express cave-
olin-1 [48].
In summary, we have found that Kv1.5 and caveolin-3 fail to
coimmunoprecipitate from, and reside in diﬀerent locales in rat
and canine cardiac myocytes and the failure to detect the chan-
nel in raft fractions, it seems likely that caveolae and lipid raft
domains play little or no role in the localization of Kv1.5 in na-
tive adult cardiac myocytes.
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